- Home
- ERAS vs AMBC Comparison
ERAS vs AMBC Comparison
Compare ERAS & AMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- AMBC
- Stock Information
- Founded
- ERAS 2018
- AMBC 1971
- Country
- ERAS United States
- AMBC United States
- Employees
- ERAS N/A
- AMBC N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- AMBC Property-Casualty Insurers
- Sector
- ERAS Health Care
- AMBC Finance
- Exchange
- ERAS Nasdaq
- AMBC Nasdaq
- Market Cap
- ERAS 484.4M
- AMBC 411.3M
- IPO Year
- ERAS 2021
- AMBC 1991
- Fundamental
- Price
- ERAS $1.41
- AMBC $8.28
- Analyst Decision
- ERAS Strong Buy
- AMBC Strong Buy
- Analyst Count
- ERAS 6
- AMBC 2
- Target Price
- ERAS $4.83
- AMBC $12.50
- AVG Volume (30 Days)
- ERAS 852.4K
- AMBC 994.5K
- Earning Date
- ERAS 08-11-2025
- AMBC 08-07-2025
- Dividend Yield
- ERAS N/A
- AMBC N/A
- EPS Growth
- ERAS N/A
- AMBC N/A
- EPS
- ERAS N/A
- AMBC N/A
- Revenue
- ERAS N/A
- AMBC $253,912,000.00
- Revenue This Year
- ERAS N/A
- AMBC N/A
- Revenue Next Year
- ERAS N/A
- AMBC $18.20
- P/E Ratio
- ERAS N/A
- AMBC N/A
- Revenue Growth
- ERAS N/A
- AMBC 125.08
- 52 Week Low
- ERAS $1.01
- AMBC $5.99
- 52 Week High
- ERAS $3.31
- AMBC $13.64
- Technical
- Relative Strength Index (RSI)
- ERAS 40.59
- AMBC 56.27
- Support Level
- ERAS $1.34
- AMBC $8.13
- Resistance Level
- ERAS $1.81
- AMBC $8.87
- Average True Range (ATR)
- ERAS 0.12
- AMBC 0.39
- MACD
- ERAS -0.03
- AMBC -0.03
- Stochastic Oscillator
- ERAS 7.45
- AMBC 60.71
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.